Narrative enhancement and cognitive therapy (NECT) to improve social functioning in people with serious mental illness: study protocol for a stepped-wedge cluster randomized controlled trial
J. Dubreucq,
M. Faraldo,
M. Abbes,
B. Ycart,
H. Richard-Lepouriel,
S. Favre,
F. Jermann,
J. Attal,
M. Bakri,
T. Cohen,
C. Cervello,
I. Chereau,
C. Cognard,
M. De Clercq,
A. Douasbin,
J. Y. Giordana,
E. Giraud-Baro,
N. Guillard-Bouhet,
E. Legros-Lafarge,
M. Polosan,
A. Pouchon,
M. Rolland,
N. Rainteau,
C. Roussel,
C. Wangermez,
P. T. Yanos,
P. H. Lysaker,
N. Franck
Affiliations
J. Dubreucq
Centre de Neurosciences Cognitive, UMR 5229, CNRS & Université Lyon 1
M. Faraldo
Centre Référent de Réhabilitation Psychosociale et de Remédiation Cognitive (C3R), Centre Hospitalier Alpes Isère
M. Abbes
Centre Référent de Réhabilitation Psychosociale et de Remédiation Cognitive (C3R), Centre Hospitalier Alpes Isère
B. Ycart
Laboratoire Jean Kuntzmann, CNRS UMR 5224, Université Grenoble-Alpes
H. Richard-Lepouriel
Department of Psychiatry, Mood disorders Unit, Geneva University Hospital
S. Favre
Department of Psychiatry, Mood disorders Unit, Geneva University Hospital
F. Jermann
Department of Psychiatry, Mood disorders Unit, Geneva University Hospital
J. Attal
Service Universitaire de Psychiatrie Adulte, Hôpital la Colombière, CHRU Montpellier, Université Montpellier 1
M. Bakri
Centre de Réhabilitation Psychosociale et de Remédiation Cognitive (C2R), CH Drôme Vivarais
T. Cohen
Centre Référent de Réhabilitation Psychosociale et de Remédiation Cognitive (C3R), Centre Hospitalier Alpes Isère
C. Cervello
Centre Ressource de Réhabilitation Psychosociale et de Remédiation Cognitive, Centre Hospitalier Le Vinatier
I. Chereau
Fondation FondaMental
C. Cognard
Unité Ariane de rehabilitation psychosociale, EPSM
M. De Clercq
Centre Départemental de Réhabilitation Psychosociale des Glières
A. Douasbin
Unité Ariane de rehabilitation psychosociale, EPSM
J. Y. Giordana
Centre Hospitalier Sainte Marie de Nice
E. Giraud-Baro
Clinique du Dauphiné- Groupe Sinoué
N. Guillard-Bouhet
CREATIV & URC Pierre Deniker, CH Laborit
E. Legros-Lafarge
Centre Référent de Réhabilitation Psychosociale de Limoges C2RL, CH Esquirol
M. Polosan
Centre Expert Troubles Bipolaires, Service Universitaire de Psychiatrie
A. Pouchon
Centre Expert Troubles Bipolaires, Service Universitaire de Psychiatrie
M. Rolland
Centre Ressource de Réhabilitation Psychosociale et de Remédiation Cognitive, Centre Hospitalier Le Vinatier
N. Rainteau
Service Universitaire de Psychiatrie Adulte, Hôpital la Colombière, CHRU Montpellier, Université Montpellier 1
C. Roussel
Centre Départemental de Réhabilitation Psychosociale des Glières
C. Wangermez
CREATIV & URC Pierre Deniker, CH Laborit
P. T. Yanos
John Jay College of Criminal Justice, City University of New York
P. H. Lysaker
Roudebush VA Medical Center, Indiana University School of Medicine
N. Franck
Centre de Neurosciences Cognitive, UMR 5229, CNRS & Université Lyon 1
Abstract Background Self-stigma is highly prevalent in serious mental illness (SMI) and is associated with poorer clinical and functional outcomes. Narrative enhancement and cognitive therapy (NECT) is a group-based intervention combining psychoeducation, cognitive restructuring and story-telling exercises to reduce self-stigma and its impact on recovery-related outcomes. Despite evidence of its effectiveness on self-stigma in schizophrenia-related disorders, it is unclear whether NECT can impact social functioning. Methods This is a 12-centre stepped-wedge cluster randomized controlled trial of NECT effectiveness on social functioning in SMI, compared to treatment as usual. One hundred and twenty participants diagnosed with schizophrenia, bipolar disorder or borderline personality disorder will be recruited across the 12 sites. The 12 centres participating to the study will be randomized into two groups: one group (group 1) receiving the intervention at the beginning of the study (T0) and one group (group 2) being a control group for the first 6 months and receiving the intervention after (T1). Outcomes will be compared in both groups at T0 and T1, and 6-month and 12-month outcomes for groups 1 and 2 will be measured without a control group at T2 (to evaluate the stability of the effects over time). Evaluations will be conducted by assessors blind to treatment allocation. The primary outcome is personal and social performance compared across randomization groups. Secondary outcomes include self-stigma, self-esteem, wellbeing, quality of life, illness severity, depressive symptoms and personal recovery. Discussion NECT is a promising intervention for reducing self-stigma and improving recovery-related outcomes in SMI. If shown to be effective in this trial, it is likely that NECT will be implemented in psychiatric rehabilitation services with subsequent implications for routine clinical practice. Trial registration ClinicalTrials.gov NCT03972735 . Trial registration date 31 May 2019.